Initial reduction of oxidative stress by angiotensin receptor blocker contributes long term outcomes after percutaneous coronary intervention.

Noro, Tadanori; Takehara, Naofumi; Sumitomo, Kazuhiro; Takeuchi, Toshiharu; Ishii, Yoshinao; Kato, Jun-Ichi; Kawabe, Jun-Ichi; Hasebe, Naoyuki

Noro, Tadanori; Takehara, Naofumi; Sumitomo, Kazuhiro; Takeuchi, Toshiharu; Ishii, Yoshinao; Kato, Jun-Ichi; Kawabe, Jun-Ichi; Hasebe, Naoyuki.

Afiliação

Noro T; Department of Cardiology, Asahikawa Medical University Japan.
Takehara N; Department of Cardiovascular Regeneration and Innovation, Asahikawa Medical University Japan.
Sumitomo K; Department of Cardiology, Asahikawa Medical University Japan.
Takeuchi T; Department of Cardiology, Asahikawa Medical University Japan.
Ishii Y; Department of Cardiology, Asahikawa City Hospital Japan.
Kato J; Department of Cardiology, Asahikawa Kosei General Hospital Japan.
Kawabe J; Department of Cardiovascular Regeneration and Innovation, Asahikawa Medical University Japan.
Hasebe N; Department of Cardiology, Asahikawa Medical University Japan.

Am J Cardiovasc Dis ; 4(4): 159-67, 2014.

Article em En | MEDLINE | ID: mdl-25628957

Palavras-chave

Angiotensin receptor blocker; PCI; ROS; mononuclear cells; oxidative stress

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Am J Cardiovasc Dis Ano de publicação: 2014 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google